RAC Regulatory Strategic Planning 2

Question 1

When developing a regulatory strategy for a combination product in the US, which FDA center typically takes lead jurisdiction?

Accepted Answer

The center with the most expertise in the primary mode of action

Answer

FDA assigns lead jurisdiction to the center whose regulation is most appropriate based on the primary mode of action of the combination product.

Question 2

A company is planning global market entry for a Class II medical device. Which regulatory pathway typically offers the fastest US market access?

Accepted Answer

510(k) with predicate

Answer

A 510(k) submission demonstrating substantial equivalence to a legally marketed predicate device is the fastest pathway for Class II devices.

Question 3

In regulatory strategic planning, a 'critical path' analysis primarily helps identify:

Accepted Answer

Activities that directly impact the overall project timeline

Answer

Critical path analysis identifies the sequence of dependent activities that determine the minimum time required to complete a project.

Question 4

Which of the following best describes a 'regulatory gap analysis' in strategic planning?

Accepted Answer

Assessing current dossier status against requirements for target markets

Answer

A regulatory gap analysis compares the existing data package against the submission requirements for target regulatory agencies to identify what additional work is needed.

Question 5

Under ICH E8(R1), which approach is emphasized for clinical trial design in regulatory strategy?

Accepted Answer

Risk-based and fit-for-purpose design tailored to the specific question

Answer

ICH E8(R1) emphasizes a risk-proportionate, fit-for-purpose approach to clinical study design that focuses on quality factors critical to the study's objectives.

(RAC) Regulatory Affairs Certification Practice Test

(RAC) Regulatory Affairs Certification Practice Test

RAC Regulatory Strategic Planning 2